Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results 2024-12-20T11:26:21-05:00December 20th, 2024| share this article![#item_full_content] Read More share this article! Related Posts Here are the 3 things behind the Friday stock market rally that almost wasn’t December 20th, 2024 Apple AI feature under fire after false Luigi Mangione headline December 20th, 2024 Number of millennial 401(k) millionaires jumps 400%: Here’s what it takes to reach seven-figure status December 20th, 2024 Trump is set to inherit a ‘strong’ economy. But his and Musk’s decisions already hint at ‘economic disaster,’ critics say December 20th, 2024
